Wealthcare Capital Management’s AbbVie ABBV Stock Holding History

Wealthcare Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-973	Closed	-$204K	–	79
2025 Q1	$204K	Buy	+973	New	+$189K	0.02%	89
2021 Q2	–	Sell	-416	Closed	-$45K	–	80
2021 Q1	$45K	Buy	+416	New	+$44.5K	﹤0.01%	145
2020 Q2	–	Sell	-39	Closed	-$3K	–	54
2020 Q1	$3K	Sell	39 -65	-63%	-$5.54K	﹤0.01%	192
2019 Q4	$9K	Buy	+104	New	+$8.63K	﹤0.01%	193
2017 Q2	–	Sell	-13	Closed	-$1K	–	177
2017 Q1	$1K	Hold	13	–	–	﹤0.01%	165
2016 Q4	$1K	Sell	13 -67	-84%	-$4.09K	﹤0.01%	162
2016 Q3	$5K	Hold	80	–	–	﹤0.01%	147
2016 Q2	$5K	Hold	80	–	–	﹤0.01%	145
2016 Q1	$5K	Hold	80	–	–	﹤0.01%	155
2015 Q4	$5K	Hold	80	–	–	﹤0.01%	166
2015 Q3	$4K	Sell	80 -365	-82%	-$23.8K	﹤0.01%	190
2015 Q2	$30K	Sell	445 -2,668	-86%	-$174K	﹤0.01%	128
2015 Q1	$182K	Buy	3,113 +3,033	+3,791%	+$183K	0.02%	102
2014 Q4	$5K	Buy	80 +13	+19%	+$820	﹤0.01%	151
2014 Q3	$4K	Hold	67	–	–	﹤0.01%	216
2014 Q2	$4K	Buy	+67	New	+$3.52K	﹤0.01%	152
2014 Q1	–	Sell	-37	Closed	-$2K	–	162
2013 Q4	$2K	Hold	37	–	–	﹤0.01%	105
2013 Q3	$2K	Hold	37	–	–	﹤0.01%	103
2013 Q2	$2K	Buy	+37	New	+$1.62K	﹤0.01%	106

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wealthcare Capital Management's ABBV Position: Q2 2025 in Review

Wealthcare Capital Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 973 shares — an estimated $204K sold.

Wealthcare Capital Management first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $204K in Q1 2025. 3,788 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Wealthcare Capital Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Wealthcare Capital Management sold 973 AbbVie shares in Q2 2025, an estimated $204K.
Wealthcare Capital Management first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
Wealthcare Capital Management's AbbVie position peaked at $204K in Q1 2025.
3,788 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Wealthcare Capital Management's 13F filing for Q2 2025, filed 22 Jul 2025.